Docket Room
HB 2246·TN·house

Health Care - As enacted, authorizes a physician to perform stem cell therapy or regenerative medicine therapy that is not approved by the United States food and drug administration if such therapy is used for a treatment or procedure that is within the scope of practice of the physician; makes related changes. - Amends TCA Title 63 and Title 68.

Signed into LawFiled Feb 2, 2026
Sponsor: Hurt
Latest Action

Pub. Ch. 1016

May 26, 2026

Share

Track this bill

Get real-time alerts when HB 2246 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice